Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fonar Corporation stock logo
FONR
Fonar
$15.42
+3.1%
$13.57
$12.00
$18.68
$95.57M0.9917,131 shs11,698 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.49
-1.4%
$2.53
$0.82
$3.38
$90.40M1.141.76 million shs639,233 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$8.06
+2.4%
$6.62
$3.72
$11.78
$89.87M1.1180,505 shs13,498 shs
OSR Holdings, Inc. stock logo
OSRH
OSR
$1.46
+5.4%
$1.33
$1.02
$13.40
$28.05M1.612.41 million shs62,028 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fonar Corporation stock logo
FONR
Fonar
+0.54%+6.02%+3.89%+10.32%-6.50%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+0.80%+6.78%-2.33%+69.13%+147.06%
Nutriband Inc. stock logo
NTRB
Nutriband
-1.38%+1.94%+26.53%+36.16%+45.74%
OSR Holdings, Inc. stock logo
OSRH
OSR
+2.22%+5.34%+2.30%-19.77%+137,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fonar Corporation stock logo
FONR
Fonar
1.7486 of 5 stars
0.03.00.00.03.30.81.9
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.9922 of 5 stars
3.52.00.00.02.60.00.6
Nutriband Inc. stock logo
NTRB
Nutriband
3.3368 of 5 stars
3.55.00.00.02.61.70.6
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fonar Corporation stock logo
FONR
Fonar
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00262.17% Upside
Nutriband Inc. stock logo
NTRB
Nutriband
3.00
Buy$13.0061.29% Upside
OSR Holdings, Inc. stock logo
OSRH
OSR
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OSRH, MBOT, FONR, and NTRB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fonar Corporation stock logo
FONR
Fonar
$102.88M0.93$3.19 per share4.84$24.78 per share0.62
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M41.99N/AN/A$0.58 per share13.90
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/A($3.87) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fonar Corporation stock logo
FONR
Fonar
$10.57M$1.2512.33N/A8.19%5.31%3.97%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$0.90N/AN/AN/A-415.93%-68.25%-60.40%9/2/2025 (Estimated)
OSR Holdings, Inc. stock logo
OSRH
OSR
-$2.41MN/A0.00N/AN/A-36.89%-19.14%N/A

Latest OSRH, MBOT, FONR, and NTRB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/30/2025Q1 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/20/2025Q1 2025
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A-$1.04N/A-$1.04N/A$0.76 million
5/15/2025Q3 2025
Fonar Corporation stock logo
FONR
Fonar
N/A$0.37N/A$0.37N/AN/A
4/28/2025Q4 2025
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fonar Corporation stock logo
FONR
Fonar
N/A
10.05
9.86
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
3.71
3.48
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A
0.25
0.20

Institutional Ownership

CompanyInstitutional Ownership
Fonar Corporation stock logo
FONR
Fonar
50.64%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
OSR Holdings, Inc. stock logo
OSRH
OSR
55.30%

Insider Ownership

CompanyInsider Ownership
Fonar Corporation stock logo
FONR
Fonar
1.55%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
OSR Holdings, Inc. stock logo
OSRH
OSR
33.67%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.20 million6.11 millionNot Optionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
Nutriband Inc. stock logo
NTRB
Nutriband
1011.15 million5.12 millionNot Optionable
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A19.28 million12.79 millionN/A

Recent News About These Companies

OSR Holdings, Inc. (OSRH)
OSRH OSR Holdings, Inc.
OSR Holdings Inc OSRH

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fonar stock logo

Fonar NASDAQ:FONR

$15.42 +0.46 (+3.07%)
As of 12:39 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.48 -0.04 (-1.39%)
As of 12:40 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$8.06 +0.19 (+2.41%)
As of 12:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

OSR stock logo

OSR NASDAQ:OSRH

$1.46 +0.08 (+5.43%)
As of 12:17 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.